Solas BioVentures Fund II, LP — Form D/A
Solas BioVentures Fund II, LP of CHATTANOOGA, TN, a pooled investment fund, filed a Form D amendment with the SEC on 2022-07-05. $35.1M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-07-05
- Form: D/A
- Accession: 0001931434-22-000003
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $35.1M
- Minimum investment: $500K
- Investors: 88
- Date of first sale: 2020-06-05
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-369247
Issuer
- Name: Solas BioVentures Fund II, LP
- CIK: 0001813747
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 412 Georgia Ave., CHATTANOOGA, TN, 37403
- Phone: 423-243-3460
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Charles David Adair | Executive Officer | CHATTANOOGA, TN |
| Mark na Hackett | Executive Officer | CHATTANOOGA, TN |
| Michael NA Hoey | Executive Officer | CHATTANOOGA, TN |
| Charles David Adair | Promoter | CHATTANOOGA, TN |
| Mark na Hackett | Promoter | CHATTANOOGA, TN |
| Michael NA Hoey | Promoter | CHATTANOOGA, TN |
| n/a na Solas BioVentures Management, LLC | Promoter | CHATTANOOGA, TN |
| n/a na Solas Partners II, LLC | Promoter | CHATTANOOGA, TN |
Other filings by this issuer (2)
More